ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000250874.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.008949695	Resistant
ENSG00000250874.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.034382724	Resistant